Cargando…
Selection of a novel strain of Christensenella minuta as a future biotherapy for Crohn’s disease
Microbiome-based therapies for inflammatory bowel diseases offer a novel and promising therapeutic approach. The human commensal bacteria of the species Christensenella minuta (C. minuta) have been reported consistently missing in patients affected by Crohn’s disease (CD) and have been documented to...
Autores principales: | Relizani, Karima, Le Corf, Katy, Kropp, Camille, Martin-Rosique, Rebeca, Kissi, Déborah, Déjean, Guillaume, Bruno, Lisa, Martinez, Ccori, Rawadi, Georges, Elustondo, Frédéric, Mazier, Wilfrid, Claus, Sandrine P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001714/ https://www.ncbi.nlm.nih.gov/pubmed/35411016 http://dx.doi.org/10.1038/s41598-022-10015-3 |
Ejemplares similares
-
A New Strain of Christensenella minuta as a Potential Biotherapy for Obesity and Associated Metabolic Diseases
por: Mazier, Wilfrid, et al.
Publicado: (2021) -
The Keystone commensal bacterium Christensenella minuta DSM 22607 displays anti-inflammatory properties both in vitro and in vivo
por: Kropp, Camille, et al.
Publicado: (2021) -
Identifying a Novel Bile Salt Hydrolase from the Keystone Gut Bacterium Christensenella minuta
por: Déjean, Guillaume, et al.
Publicado: (2021) -
Genome Sequence of Christensenella minuta DSM 22607(T)
por: Rosa, Bruce A., et al.
Publicado: (2017) -
Biocatalytic Synthesis of D-Allulose Using Novel D-Tagatose 3-Epimerase From Christensenella minuta
por: Wang, Yang, et al.
Publicado: (2020)